Related to this, the brain renin–angiotensin system (RAS) and the RhoA/Rho kinase (ROCK) pathway, which are involved in dopaminergic neurodegeneration in PD as key mediators of oxidative stress and neuroinflammation, are also involved in dyskinesia development [40,41]. The gene discussed is REN; the disease is drug-induced dyskinesia.